Aster DM Healthcare enterprise value

Share price at each year-end

Tap a line for its trend	Currentlast 12M	FY26Mar 2026	FY25Mar 2025	FY24Mar 2024	FY23Mar 2023	FY22 and earlierAlpha Plus


35,191	—	—	—	—	FY22 and earlierEvery year the company has filed comes with Alpha Plus.
229	229	166	85.5	390
258	258	223	470	412
701	701	642	669	2,287
35,921	—	—	—	—
472	472	476	584	1,898
₹693.28	—	—	—	—

5,535	5,535	4,294	5,699	7,148
12.7%	12.7%	15.0%	11.7%	32.0%
0.02×	—	—	—	—

7.37×	—	—	—	—
37.50×	—	—	—	—
52.24×	—	—	—	—
201.35×	—	—	—	—
4,876	4,643	4,138	3,699	11,933
958	901	765	578	1,565
688	637	516	358	785
—	656	425	158	1,834
178	178	68.3	−648	986
—	166	52.8	−691	969
—	478	357	806	848

Open the chart

From the company's filings with NSE and BSE (Ind-AS), consolidated. For information only, not investment advice.

alphave

ASTERDM₹679.20

Aster DM Healthcare Ltd.

· Pharma & Health

₹ CrorePeersAPOLLOHOSP MAXHEALTH KIMS COHANCE WOCKPHARMA SYNGENE GLAND LALPATHLABMcap ₹35,191 Cr

HighlightsEnterprise Value Multiples Per ShareAnnuals · FY-end closes

In ₹ Crore except Per Share 12 Months Ending	FY23 31/03/2023	FY24 31/03/2024	FY25 31/03/2025	FY26 31/03/2026	Current/LTM TTM · last close
Market Capitalization	—	—	—	—	35,191.4
- Cash, Equiv & ST Investments	389.8	85.5	166.0	229.5	229.5
+ Minority Interest	412.4	470.3	223.4	257.8	257.8
+ Total Debt	2,287.5	669.3	642.2	701.2	701.2
Enterprise Value	—	—	—	—	35,920.9
Net Debt (memo)	1,897.7	583.8	476.2	471.7	471.7
EV per Share	—	—	—	—	693.28

Total Capital	7,147.9	5,699.4	4,293.6	5,534.9	5,534.9
Total Debt/Total Capital	32.00	11.74	14.96	12.67	12.67
Total Debt/EV	—	—	—	—	0.02

EV/Sales	—	—	—	—	7.37
EV/EBITDA	—	—	—	—	37.50
EV/EBIT	—	—	—	—	52.24
EV/Free Cash Flow	—	—	—	—	201.35
Reference Items — Trailing FY Values
Sales	11,932.9	3,698.9	4,138.5	4,643.2	4,876.0
EBITDA	1,565.3	578.0	764.5	901.0	958.0
EBIT	784.8	358.0	515.7	636.8	687.7
Operating Cash Flow	1,834.0	157.8	425.1	655.9	—
Free Cash Flow	985.8	-647.8	68.3	178.4	178.4
FCFF (free cash flow to the firm)	969.1	-691.3	52.8	165.9	—
Capital Expenditure	848.2	805.6	356.7	477.5	—

Market Cap/EV/multiples pair each (split/bonus-adjusted) FY-end close with the latest filed share count; Current column uses the last close. Market Capitalization is a market-level figure — identical across Consolidated/Standalone (the accounting rows below differ). No consensus estimates → no Est columns. Click any row to chart it.

« ‹ › »Latest: FY26 · ConsolidatedFA Financial Analysis · alphave

Data & compliance. Descriptive financial information from official NSE/BSE filings — for information and education only, not investment advice, a recommendation, or a valuation. Standalone = parent entity; consolidated includes subsidiaries. Historical multiples pair each fiscal year's filed figures with that FY-end market close; the Current column uses the last close with the latest filed annuals. Figures are cross-verified via accounting identities and NSE×BSE agreement — XBRL cross-verified ✓ 95%.